companydata.dkcompanydata.dk

THERAZONE ApS: Financial statements 2016

CVR: 27255574

Source: annual report 2016, Danish Business Authority

01/01/201631/12/2016

THERAZONE ApS (CVR 27255574) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 238,343 and a net result of DKK 453,298 compared with DKK 484,500 the year before. That is an increase of 868.3% compared with the year before. Equity in the 2016 report amounted to DKK 1,343,538. The solvency ratio was 95.7%.

Gross Profit
DKK 238,343
Profit/Loss
DKK 453,298
Equity
DKK 1,343,538
Total Assets
DKK 1,403,487

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-238 t.453 t.1.3 mio.-
2015-25 t.485 t.890 t.-
2014-25 t.509 t.406 t.-
2013--1 t.-234 t.-103 t.-
2012--12 t.193 t.131 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like THERAZONE ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2016

THERAZONE ApS: The 2015 annual report is outJun 1, 2016

THERAZONE ApS has published its annual report for 2015. Gross profit came to DKK 24,614, and the net result was DKK 484,500.

About THERAZONE ApS

THERAZONE ApS is a Danish company of the type Anpartsselskab based in Dragør, founded in 2003. The company is registered under the industry Investering for egen regning. The management consists of Thomas Magnussen. The company is owned by Thomas Magnussen. According to the 2024 annual report, the company had an average of 2 employees. In 2024, the company reported a gross profit of DKK -255,949 and a net result of DKK 4,003,809 compared with DKK 2,462,806 the year before. Equity in the 2024 report amounted to DKK 44,842,105.

Source: annual report 2024, Danish Business Authority